Atlas Trials

Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women

Clinical trial NCT05755269 · TERMINATED

Trial details

NCT number
NCT05755269
Sponsor
Mayo Clinic
Status
TERMINATED
Study type
OBSERVATIONAL
Breast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast CarcinomaBreast Lobular Carcinoma In Situ
Start date
2023-03-14
Primary completion
2025-12-31
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.